Moderna begins trial of omicron-specific vaccine booster
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the omicron variant of the coronavirus.
The trials will involve a total of 600 adults — half…
Read More...
Read More...